Simulations Plus Q3 2025 Earnings Preview
Source: SeekingAlpha
2025-07-13 17:35:00 ET
More on Simulations Plus
- Simulations Plus: Further Downside Is Likely (Rating Downgrade)
- Simulations Plus: Benefiting From FDA Modernization And AI
- Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations
- Seeking Alpha’s Quant Rating on Simulations Plus
- Historical earnings data for Simulations Plus
Read the full article on Seeking Alpha
For further details see:
Simulations Plus Q3 2025 Earnings Preview
Simulations Plus Inc.
NASDAQ: SLP
SLP Trading
0.82% G/L:
$12.32 Last:
44,832 Volume:
$12.36 Open:
SLP Latest News
March 03, 2026 07:55:00 am
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
February 09, 2026 06:45:00 pm
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
January 21, 2026 04:05:00 pm
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
SLP Stock Data
$281,347,060
16,298,587
16.67%
64
N/A
Healthcare Providers & Services
Healthcare
US
Research Triangle Park
